AI Article Synopsis

  • The emergence of new SARS-CoV-2 variants presents challenges for vaccine effectiveness, diagnostics, and public health efforts.
  • A novel portable platform for rapid PCR testing in under 30 minutes has been developed to detect SARS-CoV-2 variants and Influenza A and B.
  • This technology aims to improve surveillance of viral variants and enhance patient management by using existing clinical samples for testing.

Article Abstract

The rise of highly transmissible SARS-CoV-2 variants brings new challenges and concerns with vaccine efficacy, diagnostic sensitivity, and public health responses to end the pandemic. Widespread detection of variants is critical to inform policy decisions to mitigate further spread, and postpandemic multiplexed screening of respiratory viruses will be necessary to properly manage patients presenting with similar respiratory symptoms. In this work, a portable, magnetofluidic cartridge platform for automated polymerase chain reaction testing in <30 min is developed. Cartridges are designed for multiplexed detection of SARS-CoV-2 with either identification of variant mutations or screening for Influenza A and B. Moreover, the platform can perform identification of B.1.1.7 and B.1.351 variants and the multiplexed SARS-CoV-2/Influenza assay using archived clinical nasopharyngeal swab eluates and saliva samples. This work illustrates a path toward affordable and immediate testing with potential to aid surveillance of viral variants and inform patient treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011450PMC
http://dx.doi.org/10.1002/admt.202101013DOI Listing

Publication Analysis

Top Keywords

point-of-care platform
4
platform rapid
4
rapid multiplexed
4
multiplexed detection
4
detection sars-cov-2
4
sars-cov-2 variants
4
variants respiratory
4
respiratory pathogens
4
pathogens rise
4
rise highly
4

Similar Publications

Context: Point-of-care ultrasound (POCUS) has diverse applications across various clinical specialties, serving as an adjunct to clinical findings and as a tool for increasing the quality of patient care. Owing to its multifunctionality, a growing number of medical schools are increasingly incorporating POCUS training into their curriculum, some offering hands-on training during the first 2 years of didactics and others utilizing a longitudinal exposure model integrated into all 4 years of medical school education. Midwestern University Arizona College of Osteopathic Medicine (MWU-AZCOM) adopted a 4-year longitudinal approach to include POCUS education in 2017.

View Article and Find Full Text PDF

Nucleic acid detection plays a crucial role in various applications, including disease diagnostics, research development, food safety, and environmental health monitoring. A rapid, point-of-care (POC) nucleic acid test can greatly benefit healthcare system by providing timely diagnosis for effective treatment and patient management, as well as supporting diseases surveillance for emerging pandemic diseases. Recent advancements in nucleic acids technology have led to rapid assays for single-stranded nucleic acids that can be integrated into simple and miniaturized platforms for ease of use.

View Article and Find Full Text PDF

Trends in Aptasensing and the Enhancement of Diagnostic Efficiency and Accuracy.

ACS Synth Biol

January 2025

Biosensors and Nanobiotechnology Laboratory, Chemical Sciences, Faculty of Science, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE 1410, Brunei Darussalam.

The field of healthcare diagnostics is navigating complex challenges driven by evolving patient demographics and the rapid advancement of new technologies worldwide. In response to these challenges, these biosensors offer distinctive advantages over traditional diagnostic methods, such as cost-effectiveness, enhanced specificity, and adaptability, making their integration with point-of-care (POC) platforms more feasible. In recent years, aptasensors have significantly evolved in diagnostic capabilities through the integration of emerging technologies such as microfluidics, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems, wearable devices, and machine learning (ML), driving progress in precision medicine and global healthcare solutions.

View Article and Find Full Text PDF

Advancements in Porous Silicon Biosensors for Point of Care, Wearable, and Implantable Applications.

ACS Appl Mater Interfaces

January 2025

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.

Biosensors play a critical role in modern diagnostics, offering high sensitivity and specificity for detecting various relevant clinical analytes as well as real-time monitoring and integrability in point-of-care (POC) platforms and wearable/implantable devices. Among the numerous materials used as biosensing substrates, porous silicon (pSi) has garnered significant attention due to its tunable properties, ease of fabrication, large surface area, and versatile surface chemistry. These attributes make pSi an ideal platform for transducer development, particularly in the fabrication of optical and electrochemical biosensors.

View Article and Find Full Text PDF

Tuberculosis (TB) is the second deadliest infectious disease worldwide. Current TB diagnostics utilize sputum samples, which are difficult to obtain, and sample processing is time-consuming and difficult. This study developed an integrated diagnostic platform for the rapid visual detection of Mycobacterium tuberculosis (Mtb) in breath samples at the point-of-care (POC), especially in resource-limited settings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!